Real‐life efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir in chronic hepatitis C patients in Hong Kong
2017 ◽
Vol 32
(6)
◽
pp. 1230-1233
◽
Keyword(s):
2016 ◽
Vol 64
(2)
◽
pp. S765-S766
◽
Keyword(s):
2018 ◽
Vol 68
◽
pp. S299-S300
◽
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Vol 12
(2)
◽
pp. 133-142
◽
2016 ◽
Vol 6
◽
pp. S9
Keyword(s):